Arrowhead Pharmaceuticals Inc.

In News

Arrowhead Pharmaceuticals to Present New Clinical Data at the European Society of Cardiology Congress - Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. - Aug 24, 2026

Could Arrowhead Pharmaceuticals (ARWR)’s Plozasiran Become the Catalyst for a Major Stock Re-rating? - Yahoo Finance

Yahoo Finance - Aug 28, 2026

Arrowhead Pharmaceuticals Reports Fiscal 2026 Third Quarter Results - Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. - Aug 04, 2026

Have Arrowhead Pharmaceuticals Insiders Been Selling Stock? - simplywall.st

simplywall.st - Aug 24, 2026

Arrowhead Pharmaceuticals to Participate in Upcoming June 2026 Events - Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. - Jun 02, 2026

Arrowhead Pharmaceuticals Reports Fiscal 2026 Second Quarter Results - Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. - May 07, 2026

Arrowhead Pharmaceuticals Reports Fiscal 2026 First Quarter Results - Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. - Feb 05, 2026

Arrowhead Pharmaceuticals to Webcast Fiscal 2026 Second Quarter Results - Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. - Apr 20, 2026

Arrowhead Pharmaceuticals to Host a Webinar on its Cardiometabolic Pipeline as Part I of the 2026 Summer Series of R&D Webinars - Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. - Jun 18, 2026

Arrowhead Pharmaceuticals to Participate in Upcoming March 2026 Events - Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. - Feb 24, 2026

Arrowhead Pharmaceuticals Announces NMPA Approval of REDEMPLO® (plozasiran) for Familial Chylomicronemia Syndrome (FCS) in China - Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. - Jan 07, 2026

Arrowhead Pharmaceuticals Presents New Long-Term Efficacy and Safety Data for Plozasiran Across a Spectrum of Hypertriglyceridemia at the American College of Cardiology’s 75th Annual Scientific Session and Expo - Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. - Mar 28, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment